Virus Filtration Market Size $13.86 Billion By 2032, CAGR: 14.1%

Virus Filtration Market Size Worth $13.86 Billion By 2032 | CAGR: 14.1%


The global virus filtration market size is expected to reach USD 13.86 billion by 2032, according to a new study by Polaris Market Research. The report “Virus Filtration Market Share, Size, Trends, Industry Analysis Report, By Product Type (Consumables, Instruments, Services, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Some drivers of this growth include the increasing demand for biologics, rising investments in R&D by pharmaceutical companies, and the growing prevalence of chronic diseases. The market is also poised to be impacted by advancements in virus filtration technologies, such as developing new filters with improved virus retention and removal capabilities.

Increasing demand for effective virus removal and clearance during the production of biologics, vaccines, and other biological products includes virus filters, membrane filtration systems, and virus removal services catering to biopharmaceutical manufacturing, blood and plasma fractionation, and medical device manufacturing. Virus filtration is a critical step in ensuring the safety and efficacy of these products, as contamination by viruses can pose significant health risks to patients.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/virus-filtration-market/request-for-sample

In recent years increasing in the development of advanced virus filtration technologies to remove smaller and more complex viruses, the growing adoption of single-use virus filtration systems that offer reduced contamination risks, lower capital costs, and faster turnaround times, and a trend towards outsourcing virus filtration services to specialized contract manufacturing organizations to meet the growing demand for cost-effective and flexible manufacturing solutions. These trends indicate a rapidly evolving and dynamic market with significant potential for growth and innovation in the coming years.

Virus Filtration Market Report Highlights

  • Instrument segment is anticipated to grow fastest rate during the forecast period because increasing the demand for the biologicals for the treatment of chronic diseases. Some companies introduced filtration and chromatography systems in R&D and production of biologics.
  • Biologicals segment has accounted for the highest revenue share in the market and will grow at fastest rate during projected period, due to increasing in the prevalence of cancer, diabetics and blood disorders which increases the demand for biologicals.
  • Pharmaceutical and biotechnology companies’ segment is anticipated to hold largest share. Due to increase in the vaccine production and high demand for the virus filtration propels the segment growth.
  • North America dominated the global market for virus filtration in 2022, due to raising the investment in the pharmaceutical industries and also player taking initiatives in partnerships, and collaborations which propels the market expansion.
  • The global key market players include Asahi Kasei Medical, Charles River Laboratories International, Inc, Danaher, Clean Cell Inc., GE Healthcare, Lonza Group Ltd, Merck KGaA, Sartorius, Qiagen, Thermo Fisher Scientific Inc., and WuXi PharmaTech.

Polaris Market Research has segmented the Virus Filtration market report based on product type, application, end-use, and region:

Virus Filtration, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Consumables
  • Instruments
  • Services
  • Others

Virus Filtration, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Biologicals
  • Medical Devices
  • Air Purification
  • Water Purification
  • Others

Virus Filtration, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Academic Research Institutes
  • Medical Device Companies
  • Contract Research Organizations
  • Others

Virus Filtration, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa